Biogen Idec, Inc. (BIIB) Tops Q3 EPS by 32c
Tweet Send to a FriendGet Alerts BIIB Hot Sheet
Price: $229.45 +1.15%
EPS Growth %: +40.7%
Financial Fact:
Other income (expense), net: -14.29M
Today's EPS Names:
RAVN, CAMT, HAST, More
EPS Growth %: +40.7%
Financial Fact:
Other income (expense), net: -14.29M
Today's EPS Names:
RAVN, CAMT, HAST, More
Trade BIIB Now!
Biogen Idec, Inc. (NASDAQ: BIIB) reported Q3 EPS of $1.91, $0.32 better than the analyst estimate of $1.59. Revenue for the quarter came in at $1.39 billion versus the consensus estimate of $1.38 billion.
Biogen Idec, Inc. sees FY2012 EPS of $6.40-6.50, versus the consensus of $6.43.
For earnings history and earnings-related data on Biogen Idec, Inc. (BIIB) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Biogen Idec, Inc. sees FY2012 EPS of $6.40-6.50, versus the consensus of $6.43.
For earnings history and earnings-related data on Biogen Idec, Inc. (BIIB) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- Sina Corp (SINA) Tops Q1 EPS by 5c, Offers Guidance
- iSoftStone Holdings (ISS) Tops Q1 EPS by 1c; Guides Q2, FY13
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
